Диссертация (1141124), страница 25
Текст из файла (страница 25)
/Editors. Fitzpatrick`s Dermatology in GeneralMedicine. 7th ed. New York: McGraw-Hill; -2008., P.1689-1723.189. Fridkin S.K., Hageman J.C., Morrison M., Methicillin-resistant Staphylococcus aureusdisease in three communities //N. Engl J Med. -2005; -V. 352. –P.1436–1444.190. Gabillot-Carré M., Roujeau J.C. Acute bacterial skin infections and cellulites //CurrOpin Infect Dis.
-2007. -V. 20(2). -P.118-23.191. Gao Z., Tseng C.H., Pei Z. et.al. Molecular analysis of human forearm superficial skinbacterial biota //Proc Natl Acad Sci U S A. – 2007. –V.104. -P.2927–2932128192. Guberman D., Gilead L.T., Zlotogorski A. , Schamroth J.J. Bullous erysipelas: Aretrospective study of 26 patients //Am Acad Dermatol. -1999. -V.41(5 Pt 1). -P.733-737.193. Gunderson CG.
Cellulitis: definition, etiology, and clinical features. //Am J Med. –2011. V. 124(12). –P.1113–1122.194. Gunderson C.G., Martinello R.A. A systematic review of bacteremias in cellulitis and erysipelas // JInfect. -2012. –V. 64(2). –P.148-155.195. Guoqing Xia, Christiane Wolz.
Phages of Staphylococcus aureus and their impact onhost evolution. //Infection, Genetics and Evolution. -2014. –V.21. -P. 593–601196. Hadzovic-Cengic M., Sejtarija-Memisevic A., Koluder-Cimic N.,et al. Cellulitis-epidemiological and clinical characteristics //Med Arch.
-2012. –V. 66(3 Suppl 1). –P.51-53.197. Hakenberk R., Balmelle N., Weber B. еt al. Mosaic genes and mosaic chromosomes:intra- and interspecies genomic variation of streptococcus pneumoniae //Infect. Immun. -2001. –Vol.69. – P.2477-2486.198.Harriott MM, Noverr MC. Abilityinduce Staphylococcusaureus vancomycinof Candidaresistanceduringalbicans mutantspolymicrobialtobiofilmformation //Antimicrob.
Agents Chemother. -2010. –V.54. –P.3746–3755.199.Harriott MM, Noverr MC. Candidaalbicans and Staphylococcusaureus formpolymicrobial biofilms: effects on antimicrobial resistance //Antimicrob. Agents Chemother. 2009. -V.53. -P.3914-3922.200. Heagerty A.H.M. Cellulitis and erysipelas/in Treatment of Skin Disease: ComprehesiveTherapeutic Strategies, Fourth Edition/Mark G. Lebwohl, Warren R. Heymann, John BerthJones, and Ian Coulson, Saunders an imprint of Elsevier.
-2014 –P. 130-132.201. Herpertz U. Erysipelas and lymphedema //Fortschr Med. -1998. –V. 116(12). - P.3640.202. Hersh A.L., Chambers H.F., Maselli J.H., Gonzales R. National trends in ambulatoryvisits and antibiotic prescribing for skin and soft-tissue infections //Arch Intern Med. -2008. –V.168(14). –P.1585-1591203. Hofmann H, Schnopp C. New aspects of bacterial skin infections in children //PedDermatol. -2009.- V. 60 –P.183-193.204.
Horstmann R.D., Sievertsen H.J., Knobloch J., Fischetti V.A. Antipha-gocytic activityof streptococcal M protein: selective binding of complement control protein factor H //Proc NatlAcad Sci USA. -1988. -V. 85. -P.1657–1661205. Howe P.M., Eduardo F.J., Orcutt M.A. Etiologic diagnosis of cellulitis: comparison ofaspirates obtained from the leading edge and the point of maximal inflammation //Pediatr InfectDis J. -1987, -V. 6. –P.685–686.129206.
Huletsky A., Giroux R., Rossbach V. et al.New Real-Time PCR Assay for RapidDetection of Methicillin- Resistant Staphylococcus aureus Directly from Specimens Containinga Mixture of Staphylococci // J. Clin Microb. - 2004. – V. 42 (5) - P. 1875–1884207. Humar D., Datta V., Bast D.J. et al. Streptolysin S and necrotising infections produced by group Gstreptococcus //Lancet.
-2002. –V.359(9301). –P.124-129.208. Inghammar M., Rasmussen M., Linder A. Recurrent erysipelas -risk factors and clinicalpresentation //BMC Infect Dis. -2014. -V. 14. -P.270-275209. Jeng A., Beheshti M., Li J., Nathan R. The role of beta-hemolytic streptococci incausing diffuse, nonculturable cellulitis: a prospective investigation //Medicine (Baltimore)/ 2010. –V.89. -P.217–226.210. Jenkins T.C., Sabel A.L., Sarcone E.E., et al. Skin and soft-tissue infections requiringhospitalization at an academic medical center: opportunities for antimicrobial stewardship //ClinInfect Dis. -2010. –V.51. –P.895–903.211.
Johnson K.E., Kiyatkin D.E., An A.T. et al. PCR offers no advantage over culture formicrobiologic diagnosis in cellulites /Infection. -2012. –V.40(5). –P.537- 541.212. Joo H.S., Cheung G.Y., Otto M . Antimicrobial activity of community-associatedmethicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives //J.Biol. Chem. -2011. –V.286.
-P.8933–8940213. Kallen A.J., Mu Y., Bulens S. et al. Health care-associated invasive MRSA infections,2005–2008.//JAMA. -2010. –V.304. –P.641–648.214. Kehoe M.A., Kapur V., Whatmore A.M., Musser J.M. Horizontal gene transfer amonggroup A streptococci: implications for pathogenesis and epidemiology //Trends Microbiol. 1996. –Vol.4. –N.ll. –P.436-443.215.Khadri H and Alzohairy M. Prevalence and antibiotic susceptibility pattern ofmethicillin-resistant and coagulase-negative staphylococci in a tertiary care hospital in India//International Journal of Medicine and Medical Sciences -2010. -V. 2(4).
-P.116-120.216. Ki V., Rotstein C. Bacterial skin and soft tissue infections in adults: A review of theirepidemiology, pathogenesis, diagnosis, treatment and site of care //Can J Infect Dis MedMicrobiol. -2008. -V.19 –P.173–184.217. King M.D., Humphrey B.J., Wang Y.F. et al. Emergence of community -acquiredmethicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin andsoft-tissue infections //Ann Intern Med.
-2006. V. 144. –P.309–317.218. Klein E , Smith D L , Laxminarayan R. Hospitalizations and deaths caused bymethicillin-resistant Staphylococcus aureus, United States, 1999–2005 //Emerg Infect Dis. 2007. –V. 13. –P.1840–1846.130219. Klevens R.M., Morrison M.A., Nadle J. et al. Invasive methicillin-resistantStaphylococcus aureus infections in the United States. //JAMA. -2007.
–V. 298. –P.1763–1771.220. Kluytmans J., Belkum A., Verbrugh H. Nasal carriage of Staphylococcus;Epidemiology, underlying mechanisms associated risk //Clin. Microbial. Rev. -1997. –V.10. –P.505-520.221. Koksal F, Yasar H, Samasti M Antibiotics resistant patterns of coagulase-negativestaphylococcus strains from blood cultures of septicemic in Turkey. Microbiol Res. -2009. –V.164(4).
–P.404-410222. Krasagakis K., Samonis G., Maniatakis P. et al. Bullous erysipelas: clinicalpresentation, staphylococcal involvement and methicillin resistance //Dermatology. -2006. –V.212(1). –P.31-35.223. Krause R.M. A half-century of streptococcal research: then & now //Indian. J. Med.Res. –2002. - V.115. -Р.215-241.224. Kudva A., Scheller E.V., Robinson K.M. et al. Influenza A inhibits Th17-mediated hostdefense against bacterial pneumonia in mice //J. Immunol.
-2011. –V. 186. -P.666–1674.225. Kuo C.F., Tsao N., Cheng M.H. et al, Application of the C3-binding motifof streptococcal pyrogenic exotoxin Bto protect mice from invasive group a streptococcalinfection //PLoS One. -2015 -V.10(1). –P.e0117268.226. Lancefield R.C. (1933) A serological differentiation of human and other groups ofhemolytic streptococci //J Exp Med -1933. – V. 57. –P.571–595227. Larru B., Gerber J.S. Cutaneous Bacterial Infections Caused by Staphylococcus aureusand Streptococcus pyogenes in Infants and Children Pediatr //Clin N Am. -2014. -V.61. -P.45778.228.
Latif M., Usman J., Gilani M., et al. Coagulase negative staphylococci - a fast emergingthreat //J Pak Med Assoc. -2015. –V. 65(3). –P.283-286.229. Lijek R.S., Weiser J.N. Co-infection subverts mucosal immunity in the upperrespiratory tract //Curr. Opin. Immunol. -2012. –V. 24. –P.417–423]230. Lina G., Bohach G.A., Nair S.P. et al. Standard nomenclaturefor the superantigensexpressedby Staphylococcus //J InfectDis. -2004. –V.189.
–P.2334–2336.231. Lina G., Boutite F., Tristan A. et al. Bacterial competition for human nasal cavitycolonization: role of Staphylococcalagr alleles //Appl. Environ. Microbiol. -2003. –V.69. –P.18–23.232. Lipsky B.A., Weigelt J.A., Gupta V. et al. Skin, soft tissue, bone, and joint infections inhospitalized patients: epidemiology and microbiological, clinical, and economic outcomes//Infect Control Hosp Epidemiol. -2007.
–V. 28. -P.1290–1298.131233. Liu C., Bayer A., Cosgrove S.E. et al. Clinical Practice Guidelines by the InfectiousDiseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureusInfections in Adults and Children //Clin. Infect. Dis. -2011. –V. 52. -P. 1–38.234. Lourtet-Hascoëtt J, Bicart-See A, Félicé MP et al. Is Xpert MRSA/SA SSTI real-timePCR a reliable tool for fast detection of methicillin-resistant coagulase-negative staphylococci inperiprosthetic joint infections? //Diagn Microbiol Infect Dis. -2015.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
